A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia
This study has been completed.
Study NCT00350467
Information provided by Xian-Janssen Pharmaceutical Ltd.
First Received on July 7, 2006.
Last Updated on May 18, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
